Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of earlier notice dated 26th September, 2018, Ind-Swift has informed that in the VAT matter of 926 companies/cases being investigated by the VAT Tribunal which was referred for the legal enquiry ; the company was already co-operating with the investigating agency. The agency has however now summoned company’s Director viz. N.R.Munjal for investigation. N.R.Munjal has joined the investigation.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1829.90 |
| Dr. Reddys Lab | 1308.00 |
| Cipla | 1371.30 |
| Zydus Lifesciences | 939.15 |
| Lupin | 2467.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: